Skip to search formSkip to main contentSkip to account menu

NC100150

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ferumoxtran-10

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor.
Highly Cited
2004
Highly Cited
2004
Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging
The purpose of this study was to determine the cellular distribution and degradation in rat liver following intravenous injection… 
2004
2004
Long‐term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent
To investigate the duration of liver R2* enhancement and pharmacokinetics following administration of an iron oxide nanoparticle… 
Highly Cited
2001
Highly Cited
2001
MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation.
PURPOSE To define the diagnostic potential of magnetic resonance (MR) imaging enhanced with ultrasmall superparamagnetic iron… 
Highly Cited
2000
Highly Cited
2000
NC100150 injection, a preparation of optimized iron oxide nanoparticles for positive‐contrast MR angiography
A preparation of monocrystalline iron oxide nanoparticles with an oxidized starch coating, currently in clinical trials (NC100150… 
2000
2000
Three‐dimensional MR imaging of pulmonary vessels and parenchyma with NC100150 injection (Clariscan™)
The influence of increasing doses of NC100150 Injection (Clariscan™) and echo times on visualization of pulmonary vessels and… 
2000
2000
Effect of NC100150 injection on the 1H NMR linewidth of human whole blood ex vivo: Dependency on blood oxygen tension
The linewidth of the 1H NMR signal (7.05 T) of human whole blood titrated with a superparamagnetic contrast agent (NC100150… 
1999
1999
High-resolution magnetic resonance coronary angiography of the entire heart using a new blood-pool agent, NC100150 injection: comparison with invasive x-ray angiography in pigs.
Recent developments of novel magnetic resonance intravascular contrast agents with low T1 in blood and a long intravascular half… 
1999
1999
Characterization of t1 relaxation and blood‐myocardial contrast enhancement of NC100150 injection in cardiac MRI
A new ultrasmall superparamagnetic iron oxide (Clariscan; NC100150 Injection) was studied in domestic farm pigs. The T1 effects… 
1999
1999
‘NC100150’, a preparation of iron oxide nanoparticles ideal for positive-contrast MR angiography
A laboratory-scale synthesis of NC100150 (iron oxide particles with an oxidized starch coating) was characterized by… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)